| Period Ending: | 2024 31/12 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | aa.aa | |||||||||
Total Revenues Growth | aa.aa | |||||||||
Cost Of Revenues | aa.aa | |||||||||
Gross Profit | aa.aa | |||||||||
Gross Profit Growth | aa.aa | |||||||||
Gross Profit Margin % | aa.aa | |||||||||
Other Operating Expenses, Total | aa.aa | |||||||||
| ||||||||||
Operating Income | aa.aa | |||||||||
Operating Income Growth | aa.aa | |||||||||
EBIT Margin % | aa.aa | |||||||||
Net Interest Expenses | aa.aa | |||||||||
Net Interest Expenses Growth | aa.aa | |||||||||
Interest Expense, Total | aa.aa | |||||||||
Interest And Investment Income | aa.aa | |||||||||
Other Non Operating Expenses, Total | aa.aa | |||||||||
EBT, Excl. Unusual Items | aa.aa | |||||||||
Gain (Loss) On Sale Of Assets | aa.aa | |||||||||
Other Unusual Items, Total | aa.aa | |||||||||
EBT, Incl. Unusual Items | aa.aa | |||||||||
EBT, Incl. Unusual Items Growth | aa.aa | |||||||||
EBT, Incl. Unusual Items Margin | aa.aa | |||||||||
Income Tax Expense | aa.aa | |||||||||
Net Income to Company | aa.aa | |||||||||
Minority Interest | aa.aa | |||||||||
Net Income | aa.aa | |||||||||
Net Income Growth | aa.aa | |||||||||
Net Income Margin % | aa.aa | |||||||||
Preferred Dividend and Other Adjustments | aa.aa | |||||||||
Net Income to Common Excl. Extra Items | aa.aa | |||||||||
Basic EPS - Continuing Operations | aa.aa | |||||||||
Basic EPS - Continuing Operations Growth | aa.aa | |||||||||
Diluted EPS - Continuing Operations | aa.aa | |||||||||
Diluted EPS - Continuing Operations Growth | aa.aa | |||||||||
Basic Weighted Average Shares Outstanding | aa.aa | |||||||||
Diluted Weighted Average Shares Outstanding | aa.aa | |||||||||
Dividend Per Share | aa.aa | |||||||||
Dividend Per Share Growth | aa.aa | |||||||||
EBITDA | aa.aa | |||||||||
EBITDA Growth | aa.aa | |||||||||
EBITDA Margin % | aa.aa | |||||||||
EBIT | aa.aa | |||||||||